News

Aurora Cannabis Inc. Shares Key Insights Ahead of Shareholder Meeting

Aurora Cannabis Inc. Shares Key Insights Ahead of Shareholder Meeting

Aurora Cannabis Inc. Prepares for Shareholder Engagement

Your participation is vital, regardless of the number of shares you own. We encourage you to cast your vote today.

For any questions or assistance with voting your shares, shareholders can reach out to Aurora's strategic advisor, Laurel Hill Advisory Group, at 1-877-452-7184. Their team is ready to provide support.

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) proudly announces that the management information circular for the upcoming annual general and special meeting is now accessible on the Company's website. The circular and related materials have been successfully mailed to shareholders as part of the meeting preparations.

We invite you to review the circular closely. Additionally, you can watch a brief message from our CEO, Miguel Martin, and CFO, Simona King, reflecting on our progress and aspirations for the future.

Meeting Details and Participation

The virtual meeting is scheduled for a convenient time, ensuring that all shareholders can participate, no matter their geographic location. Details on how to join the meeting via webcast will be available, along with instructions for casting your vote.

Shareholders are strongly encouraged to read the circular thoroughly and make their voices heard in the voting process. The voting deadline is approaching quickly, so ensure that your voice is counted.

Voting Recommendations and Importance

Aurora's board of directors recommends that shareholders vote FOR all director nominees and meeting resolutions. It's essential to take this opportunity seriously, as your shareholding directly influences the Company’s governance and future.

Remember, your vote is crucial! We urge you to participate and support Aurora's initiatives by voting as soon as possible.

Questions and Support for Shareholders

If you have any questions or need assistance with voting, please contact Laurel Hill Advisory Group, who can assist you with your inquiries:

Toll-Free Number: 1-877-452-7184 (for shareholders in North America)
International Contact: +1 416-304-0211 (for shareholders outside of Canada and the US)

About Aurora Cannabis Inc.

Aurora is committed to pioneering the cannabis landscape, serving medical and consumer markets worldwide. Headquartered in Edmonton, Aurora is a forefront leader in the cannabis industry, dedicated to enhancing lives through innovative products. Our diverse portfolio includes a range of exceptional brands, catering to both adult-use consumers and medical patients alike.

Aurora's common shares are publicly traded on NASDAQ and TSX under the symbol "ACB". With a commitment to quality and safety, Aurora leverages expertise and scientific research to maintain its leadership position in the cannabis market.

Frequently Asked Questions

What is the significance of the management information circular?

The management information circular details the upcoming annual general meeting and outlines key matters that shareholders need to vote on, ensuring transparency and participation.

How can shareholders participate in the virtual meeting?

Shareholders can join the virtual meeting via a provided webcast link, enabling them to engage directly in discussions about the Company's future.

When is the deadline for voting?

The deadline for submitting votes is set for a specific date prior to the meeting, enabling shareholders to express their opinions and influence Company direction.

What actions are recommended by the board of directors?

The board recommends shareholders vote FOR all nominated directors and resolutions, ensuring the Company is governed effectively with responsible oversight.

How does Aurora ensure shareholder communication?

Aurora values transparent communication with shareholders and encourages them to reach out for any inquiries through designated contact points for assistance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Montessori and Tech: A New Era of Integration

Updated Category News Views 13

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 13

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 12

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 9

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 14

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Celebree Gains Franchise Momentum: A New Frontier

Updated Category News Views 9

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 21

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 12

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 11

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading
New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 11

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
ews Section End -->

Top 5 Most Recently Viewed Articles

ABO-GROUP Sees Impressive Growth in Half-Year Performance

Updated Category News Views 186

ABO-GROUP Reports Outstanding Half-Year Results for 2024 ABO-GROUP has proudly unveiled impressive financial results for the first half of 2024, showcasing resilience and strategic growth. This period has recorded substantial double-digit growth, with a 14.3% increase attributed mainly to recent acquisitions and strong organic growth. Highlights from the First Half of...

Continue Reading
Lafayette Square Enhances Education with New Renovation Project

Updated Category News Views 188

Lafayette Square Enhances Education with New Renovation Project Lafayette Square has made a transformative investment in the educational landscape by partnering with Shift Capital and Voyage Investments to renovate a vacant warehouse into a state-of-the-art space for the El Centro de Estudiantes Big Picture Philadelphia School. This initiative reflects a strong commitment...

Continue Reading
AI Hardware Transition: The Rise of ASICs in Computing

Updated Category News Views 124

Understanding the Shift in AI Hardware The technology landscape is experiencing a transformational shift as discussions surrounding AI hardware evolve. Emerging partnerships are reshaping the way inferences are computed, highlighting the importance of specialized chips like ASICs in this competitive landscape. The ASIC Market Grows After Strategic Collaborations Recent...

Continue Reading
PetVivo Holdings Invites Shareholders to Upcoming Update Meeting

Updated Category News Views 96

PetVivo Holdings to Provide Shareholders Update Meeting PetVivo Holdings, Inc. (OTCQB: PETV and PETVW) is preparing to connect with its valued shareholders during a significant online event. The upcoming Shareholders Update Meeting will reflect on the company’s achievements in the ongoing fiscal year and present a vision for what lies ahead. This engaging session...

Continue Reading
Pasithea Therapeutics' Positive Trial Results Fuel Stock Surge

Updated Category News Views 155

Pasithea Therapeutics Corp. is riding a wave of momentum as its stock price spikes significantly, driven by compelling outcomes from its recent clinical trials. The spotlight is on the Phase 1 trial of PAS-004, a therapy aimed at tackling advanced solid tumors that carry mutations in the MAPK pathway—namely RAS, NF1, or RAF. This treatment is particularly critical for...

Continue Reading